Green Chemistry in Drug Development

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  2013-09-11

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1201/B15466-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Process R&D under the magnifying glass: organization, business model, challenges, and scientific context.

  2010cited by this paper
• Chemical process research and development in the 21st century: challenges, strategies, and solutions from a pharmaceutical industry perspective.

  2009cited by this paper
• Biocatalysis in development of green pharmaceutical processes.

  2009cited by this paper
• Development of a Chemoenzymatic Manufacturing Process for Pregabalin

  2008cited by this paper
• Optimization and Scale-up of a Pd-Catalyzed Aromatic C−N Bond Formation: A Key Step in the Synthesis of a Novel 5-HT1B Receptor Antagonist

  2008cited by this paper
• SusChem: from vision to action.

  2008cited by this paper
• A convergent approach to the synthesis of aprepitant: a potent human NK-1 receptor antagonist ☆

  2007cited by this paper
• Alternative Solvents: Shades of Green

  2007cited by this paper
• The E Factor: fifteen years on

  2007cited by this paper
• Construction of a chiral central nervous system (CNS)-active aminotetralin drug compound based on a synthesis strategy using multitasking properties of (S)-1-phenylethylamine.

  2007cited by this paper
• DrugBank: a knowledgebase for drugs, drug actions and drug targets

  2007cited by this paper
• The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders.

  2006cited by this paper
• Green Chemistry, a Pharmaceutical Perspective

  2006cited by this paper
• In search of sustainability: process R&D in light of current pharmaceutical industry challenges.

  2006cited by this paper
• Green solvents for sustainable organic synthesis: state of the art

  2005cited by this paper
• A New and Simplified Process for Preparing N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine and a Telescoped Process for the Synthesis of (1S-cis)-4-(3,4-Dichlorophenol)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine Mandelate: Key Intermediates in the Synthesis of Sertraline

  2004cited by this paper
• Pharmacology of a novel selective 5-hydroxytryptamine1B receptor antagonist, AR-A000002

  2004cited by this paper
• Effects of long-term administration of the 5-hydroxytryptamine1B receptor antagonist AR-A000002 to guinea pigs

  2004cited by this paper
• Serotonin1B receptors: from protein to physiological function and behavior.

  2004cited by this paper
• Efficient synthesis of NK(1) receptor antagonist aprepitant using a crystallization-induced diastereoselective transformation.

  2003cited by this paper
• A guide to drug discovery: Logistics of process R&D: transforming laboratory methods to manufacturing scale

  2003cited by this paper
• Practical asymmetric synthesis of aprepitant, a potent human NK-1 receptor antagonist, via a stereoselective Lewis acid-catalyzed trans acetalization reaction.

  2002cited by this paper
• Origins, current status, and future challenges of green chemistry.

  2002cited by this paper
• Metrics to ‘green’ chemistry—which are the best?

  2002cited by this paper
• Highly diastereoselective and enantioselective carbon-carbon bond formations in conjugate additions of lithiated N-Boc allylamines to nitroalkenes: enantioselective synthesis of 3,4- and 3,4,5-substituted piperidines including (-)-paroxetine.

  2001cited by this paper
• Pharmacotherapy of mental illness--a historical analysis.

  2001cited by this paper
• Review of sertraline and its clinical applications in psychiatric disorders

  2001cited by this paper
• A new synthesis of 1,2,4-triazolin-5-ones: application to the convergent synthesis of an NK1 antagonist

  2000cited by this paper
• Asymmetric synthesis of (−)-paroxetine using PLE hydrolysis

  2000cited by this paper
• High yields of meta-substituted amination products in the SNAr substitution of benzenes

  1999cited by this paper
• An efficient stereoselective synthesis of methyl (S)-3-amino-3-(3-pyridyl)propanoate

  1999cited by this paper
• Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonist.

  1998cited by this paper
• Chemical Development of CI-1008, an Enantiomerically Pure Anticonvulsant

  1997cited by this paper
• Palladium-Catalyzed Amination of Aryl Triflates and Importance of Triflate Addition Rate

  1997cited by this paper
• Enantioselective Biomimetic Transamination of β-Keto Carboxylic Acid Derivatives. An Efficient Asymmetric Synthesis of β-(Fluoroalkyl) β-Amino Acids

  1997cited by this paper
• Palladium-Catalyzed Amination of Aryl Triflates

  1997cited by this paper
• Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures(1).

  1996cited by this paper
• Palladium-catalyzed synthesis of arylamines from aryl halides. Mechanistic studies lead to coupling in the absence of tin reagents

  1995cited by this paper
• Pharmacokinetics of the 5-hydroxytryptamine1A agonist 8-hydroxy-2-(N,N-di-n-propylamino)tetralin (8-OHDPAT) in the rat after intravenous and oral administration.

  1995cited by this paper
• A Simple Catalytic Method for the Conversion of Aryl Bromides to Arylamines

  1995cited by this paper
• Enantioselective synthesis of PD144723: A potent stereospecific anticonvulsant

  1994cited by this paper
• VOLTAMMETRY MADE EASY

  1994cited by this paper
• High Pressure Organic Chemistry; XI.1 A New Convenient Synthesis of Aromatic Amines from Activated Phenols

  1990cited by this paper
• Kristallin‐flüssige Heterocycloalkane. II [1]. Synthese und kristallin‐flüssiges Verhalten substituierter 1‐Phenylpiperazine

  1986cited by this paper
• Asymmetrische reduktive Aminierung von Cycloalkanonen, 5. Synthese und absolute Konfiguration 2‐substituierter Cyclopentanamine

  1984cited by this paper
• Nontricyclic antidepressant agents derived from cis- and trans-1-amino-4-aryltetralins.

  1984cited by this paper
• Enantioselective addition of n-butyllithium to benzaldehyde in the presence of chiral lithium amides

  1984cited by this paper
• 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist.

  1981cited by this paper
• Fluorinated tricyclic neuroleptics with prolonged effects: Some new 8-chloro-3-fluoro-10-piperazino-10,11-dihydrodibenzo[ b,f ]thiepins

  1977cited by this paper
• Novel synthesis of prostaglandin F2.alpha.

  1973cited by this paper
• The Reaction of Phloroglucinol with 1-Methyl-piperazine

  1955cited by this paper
• 42. A rearrangement of o-acetamido-sulphones and -sulphides

  1935cited by this paper
• CCCCLII.—The rearrangement of hydroxy-sulphones. Part I

  1931cited by this paper
• Green chemistry

  year unknowncited by this paper

• Integrated design of solvent-antisolvent mixtures and crystallization processes powered by machine learning

  2025cites this paper
• The chronological evolution of environment benign processes in the synthesis of natural products and APIs

  2024cites this paper
• Biocatalysis: A smart and green tool for the preparation of chiral drugs

  2022cites this paper
• A Continuous Process for Buchwald–Hartwig Amination at Micro-, Lab-, and Mesoscale Using a Novel Reactor Concept

  2016cites this paper
• C–N Coupling Chemistry as a Means to Achieve a Complicated Molecular Architecture: the AR‐A2 Case Story

  2013cites this paper